An evaluation of Irish cattle herds with inconclusive serological evidence of bovine brucellosis by Hayes, M et al.
Irish Veterinary Journal Volume 62 Number 3 182
P
E
E
R
 
R
E
v
I
E
W
E
D
Irish Veterinary Journal Volume 62 Number 3
INtrODuCtION
Progress towards eradication of bovine brucellosis in Ireland
A national programme to eradicate bovine brucellosis 
in the Republic of Ireland commenced in 1965 with 
the introduction of milk ring testing for dairy herds. 
At the outset of the programme, 12% of the 105,000 
dairy herds tested positive; a further 3% of tests were 
inconclusive (Griffin and Collins 1999). At this time, the 
incidence of disease was higher in the south of Ireland 
than in the west and north-west. Good progress towards 
the goal of eradication was achieved over the following 
20 years, resulting in a recorded herd prevalence of 
0.19% during 1985 and 1986 (Griffin and Collins 1999). 
Residual disease was limited to north Cork, Limerick and 
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AbStrACt
Since 1998, there has been a steady decline in herd restrictions and de-populations in Ireland due to bovine brucellosis. There is 
concern that the interpretation of laboratory results may become increasingly problematic, as brucellosis prevalence falls in Ireland. 
Therefore, the purpose of the current study was to evaluate the infection status of Irish herds and animals with inconclusive serological 
evidence of bovine brucellosis. During 12 months from September 1, 2004, laboratory and observational epidemiological data were 
collected from all Irish herds where animal testing identified at least one animal with a complement fixation test (CFT) reading greater 
than zero and/or a positive result to the indirect enzyme-linked immunosorbent assay (iELISA). Due to the observational nature of the 
study, we have robust estimates of the relative, but not the absolute, performance of the CFT, iELISA and brucellin skin test (BST). 
Herds were divided into three categories (Group A, B or C) on the basis of test results at initial assessment. A total of 639 herds were 
enrolled into the study, and observed for at least two years following enrolment. A rising CFT titre, with a CFT reading of 111 International 
CFT Units (IU) or greater at the subsequent blood test, was generally associated with herds where other evidence of infection was also 
available. Knowledge of the CFT reading at the initial and a subsequent blood test proved useful in distinguishing false-positive and 
true-positive brucellosis results. There was poor correlation between the CFT and iELISA results, and between the CFT and BST results. 
As a result of this study, national policy has been modified to include re-sampling of all animals with CFT readings of 20 IU or greater. 
This project has also led to a reduction in the number of herds restricted, as well as restriction duration. It has also contributed to a 
reduction in the number of herds listed for contiguous tests, and therefore the potential for contiguity testing of false positive results.
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Tipperary. However, further progress was not achieved, 
with disease prevalence increasing during the 1990s. A 
total of 1,081 herds were restricted during 1998 (Griffin 
and Collins 1999), with disease spreading within, not 
just Limerick and Tipperary, but also to counties that 
had been clear for a number of years. A range of policy 
changes were introduced from February 1998 onwards, 
including the re-introduction of the pre-movement test, the 
rapid depopulation of infected herds and the treatment 
of slurry with lime prior to land spreading (Figure 1). In 
situations where lime treatment was not possible, the 
herdowner was required to store the slurry or farm yard 
manure for a prolonged period prior to spreading. Since 
1998, there has been a steady decline in herd restrictions 
and de-populations. In 2004, 2005, 2006 and 2007, the 
number of herds depopulated as a result of confirmed or 
suspected brucellosis was 68, 27, 3 and 0, respectively 
(Figure 2). If the current disease situation is maintained, 
Ireland will be eligible to achieve Officially Brucellosis Free 
(OBF) status in April 2009.
Challenges faced as disease prevalence falls
There is a fall in the positive predictive value of sero-
diagnostic testing with reducing disease prevalence. In 
other words, false positive serological reactors become 
increasingly problematic as disease levels fall. This 
issue, which has been reported in the European Union 
and New Zealand (Pouillot et al. 1998; Godfroid et al. 
2002) in association with the latter stages of brucellosis 
eradication programmes, presents a range of challenges 
for programme decision-makers. These include the 
imposition of potentially unnecessary herd restrictions, 
related trade implications and testing requirements for 
herds contiguous to those with false positive reactor 
animals (Godfroid et al. 2002). Efforts to distinguish false 
and true positive reactors have been conducted, based 
on detailed epidemiological investigations, laboratory 
testing and measures of cellular immunity (Godfroid et 
al. 2002; Saegerman et al. 2004), and improvements in 
the specificity of a national brucellosis testing programme 
have recently been reported (McGiven et al. 2008).
Study objectives
The correct interpretation of annual test results from 
all female and male cattle over 12 months of age is a 
critical component of the national programme in Ireland. 
However, the interpretation of these results may become 
increasingly problematic, as brucellosis prevalence falls in 
Ireland. The purpose of the current study was to evaluate 
the infection status of Irish herds and animals with 
inconclusive serological evidence of bovine brucellosis.
MAtErIAlS AND MEtHODS
The Irish programme
As part of the national brucellosis eradication programme, 
blood is collected annually from all female and entire 
male cattle aged 12 months and over, for serological 
testing at the Blood Testing Laboratory, Model Farm 
Road, Cork. The protocol for annual herd testing 
in Ireland is presented in Figure 3. Initially, serum is 
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Figure 1: National policy changes, relevant to the eradication of bovine 
brucellosis, between 1965 and 2004.
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Figure 2: New herd restrictions and depopulations due to bovine brucellosis in 
Ireland during 1994 to 2007. Herd depopulation data was not available for 1994 
and 1995.
IVJ_March_2009.indd   183 18/02/2009   15:07:34Irish Veterinary Journal Volume 62 Number 3 184
P
E
E
R
 
R
E
v
I
E
W
E
D
Irish Veterinary Journal Volume 62 Number 3
screened using the microtitre-serum agglutination test 
(MSAT), at a dilution of 1:14 (which provides increased 
sensitivity over the normal positive cut-off of 2:20). 
Samples failing the MSAT screening are re-tested using 
both the indirect enzyme-linked immunosorbent assay 
(iELISA) and complement fixation test (CFT). If a positive 
CFT result (considered 19.4 international units (IU) or 
greater; noting, at the time, that the titration methods 
did not allow an even result of 20 IU, the recognised 
positive cut-off) is obtained, the sera from all other 
eligible animals in the same herd are tested using both 
the CFT and iELISA (Figure 3). Serological testing is also 
conducted (in addition to the annual test) on herds that 
are contiguous to restricted herds, on animals pre- and 
post-movement, on post-abortion samples, as well as on 
animals that have been traced from diseased premises. 
A number of additional measures and obligations also 
form part of the programme. Approximately 75% of cull 
cows are blood sampled at the point of slaughter, and 
these samples are tested in the blood testing laboratory 
in Cork. A whey iELISA test is conducted monthly on 
bulk milk tank samples from all dairy herds. There is a 
legal obligation on an owner or person in charge of an 
animal that aborts to notify the Department of Agriculture, 
Fisheries and Food (who will arrange follow up testing) or 
to arrange for a registered veterinary surgeon to arrange 
for the relevant samples or specimens to be sent for 
analysis, including culture where relevant, in an approved 
laboratory. The MSAT, iELISA, CFT and culture are standard 
tests, conducted in accordance with both international 
(OIE 2004) and EU (Anon. 1964) guidelines. Movement 
restrictions are imposed on all test-positive herds, and 
rapid herd depopulation is undertaken when disease is 
considered to be present. Extended restrictions were used 
in high incidence areas to prevent re-infection. A range 
of decontamination procedures are undertaken, including 
cleansing and disinfection of housing, lime treatment of 
slurry (to raise pH to 12 or greater) or prolonged slurry 
storage if lime treatment is not feasible, and prolonged 
storage of farmyard manure prior to spreading onto land 
(Hahesy and Sheahan 2002).
The study herds
a. Selection criteria and study period
All herds in the Republic of Ireland were eligible for 
inclusion in this study. We enrolled all herds into the study 
that showed a serological response in either the CFT 
or serum iELISA at any test during the 12 months from 
September 1, 2004. Each study herd was observed from 
enrolment until the end of April 2007.
b. Herd categorisation
Each study herd was categorised on the basis of results 
from the initial test(s) conducted at the time of enrolment 
(‘the initial assessment’), as follows:
At the initial assessment, Group A herds had either  •	
conclusive evidence of brucellosis (culture-positive 
abortion, or a high CFT following a suspected abortion 
but a foetus was not available for culture) or at least 
two animals with a CFT result of 111 IU or more 
(chosen arbitrarily; in the Irish programme, this figure 
is considered indicative of infection, regardless of the 
number positive); 
At the initial assessment, Group B herds had one or  •	
more animals with a CFT reading greater than zero; 
however, Group A herd criteria were not met; and,
At the initial assessment, Group C herds had one or  •	
more animals with a positive iELISA result; however, 
Group A and/or B herd criteria were not met.
In cases where the initial assessment was a part-herd 
test, the result of the complete herd test was taken into 
account before the herd was categorised. Herds remained 
in their initial herd category, despite later events during the 
study period.
c. Herd management
Each of the study herds was managed as presented in 
Figure 3. Briefly:
Group A herds were immediately depopulated.  •	
Therefore, follow-up sampling from CFT-positive 
animals was not conducted. When feasible, however, 
the retropharyngeal and/or supramammary lymph 
nodes from these animals were submitted for bacterial 
Negative Positive
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CFT > O.I.U
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Figure 3:  A flow diagramme highlighting the protocol for annual herd testing in 
Ireland, the process of herd categorisation in this study, and the diagnostic tests 
applied to the different study groups.  A range of diagnostic tests are mentioned, 
including the microtitre serum agglutination test (MSAT), complement fixation 
test (CFT), the indirect enzyme-linked immunosorbent assay (iELISA) and the 
brucellin skin test (BST).
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culture. These farms were considered disease-free 
when they were subsequently re-populated; 
In Group B herds, all CFT-positive animals were  •	
re-bled for testing using the MSAT, CFT and iELISA. 
Where feasible, these animals were also tested 
using the brucellin skin test (BST; Brucellergene 
OCB, Synbiotics Europe, Lyon, France), in accordance 
with internationally recognised methods (OIE 2004). 
Animals with a positive CFT result at the initial and/
or a subsequent assessment were slaughtered and 
retropharyngeal and/or supramammary lymph nodes 
were collected for bacterial culture, where feasible; 
and,
In Group C herds, all cattle positive to the iELISA were  •	
re-bled for testing using the MSAT, CFT and iELISA.
Data collection
Data were collected from a range of data sources about 
each study herd, including:
The National Brucellosis Laboratory (results from  •	
the initial test and all relevant testing conducted 
subsequently);
The Animal Health Computer System (AHCS) and  •	
Animal Identification and Movement (AIM) System (a 
central national database of animal movement and 
health information, including herd depopulations); and,
The Land Parcel Identification System (LPIS;  •	
geographic information on land owned by farmers).
Furthermore, field veterinary inspectors were asked to 
collect epidemiological data from each Group B, and where 
possible Group C, herd (see below) using an investigative 
template that focused on potential linkages with any 
previously restricted herd. These linkages related to the 
history of the CFT and/or iELISA positive animals, the 
infection history of the herd and of the locality, and the 
potential for mechanical transmission to the herd, either 
by people or equipment.
Data management and analysis
Herd and animal-level data was managed in a Microsoft 
Access 2003 database. Data analyses were conducted 
in Microsoft Access, and results were presented using 
Microsoft Excel 2003 (Microsoft Corporation, Redmond, 
USA). Using StatXact (Cytel Inc. Cambridge, USA), we 
calculated McNemar’s chi square test and kappa values to 
assess the level of inter-test agreement.
rESultS
General results
During the 12 months from September 1, 2004, 639 
herds were enrolled in the study, including 10 Group A 
herds (117 CFT- and/or iELISA-positive animals), 247 
Group B herds (451 CFT- and/or iELISA-positive animals) 
and 382 Group C herds (398 iELISA-positive animals). 
The Group B and C herds were located throughout Ireland, 
whereas the Group A herds were found in counties Cavan, 
Clare, Cork, Kerry, Meath and Tipperary (Figure 4).
Group A herds
During the study period, 10 Group A herds were 
identified. Tissue samples were submitted for culture 
from three of these herds, and all were positive. At the 
initial assessment, CFT and iELISA serological data were 
available for 116 study animals from these herds. Serum 
from one study animal was haemolysed; therefore, a CFT 
result was not available. Ninty-four (81.0% of 116) study 
animals were CFT-positive (an average of 9.4 CFT-positive 
animals/herd) and 97 (82.9% of 117) were iELISA-positive. 
The distribution of the initial CFT result is presented in Table 
1. Samples containing 356 IU in the CFT were not further 
diluted and so this reading represents a reading of 356 or 
greater. There was moderate agreement between the 116 
CFT and iELISA results (kappa = 0.24, 95% confidence 
interval -0.03 to 0.46; McNemar’s chi-square P = 0.70; 
Table 2). Following the initial assessment, all Group A herds 
were rapidly depopulated. In the two years since study 
end, there has been no evidence of infection in any Group 
A herd following re-population.
Group B herds
At the initial assessment, CFT and iELISA serological data 
are available for 441 animals from 246 Group B herds. 
Sera from a further 10 animals were haemolysed, and CFT 
results are not available. At this assessment, 225 (51.0%) 
samples had a positive CFT (an average of 0.9 CFT-positive 
animals/herd), and 331 (75.1%) samples were iELISA-
positive (Table 3). There was a poor correlation between 
the initial CFT and iELISA results (kappa = -0.38, 95% 
confidence interval -0.46 to -0.31; McNemar’s chi square 
test P < 0.001).
N
A herds
C herds
B herds
Northern
Ireland
40 80  Kilometres 40 0
Figure 4. The location of the study herds.
Figure 4: The location of the study herds.
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A subsequent assessment, which included iELISA and CFT 
testing and the collection of herd-level risk factor data, 
was carried out, on average 25 days later, on 334 animals 
in 198 herds (Figure 5). The CFT results, summarised and 
in detail, at the initial and subsequent assessments 
for these 334 animals from 198 Group B herds are 
presented in Table 4 and Table 5, respectively. The correlation 
between the initial and subsequent CFT result was poor 
(kappa = 0.26; 0.18, 0.33; McNemar’s chi square test 
P < 0.001; Table 4), mainly due to a falling CFT titre at the 
subsequent test. Of 173 animals with a positive (19.4 
or greater) CFT reading at the initial assessment, 122 
(70.5%) subsequently tested negative (Table 4). The iELISA 
results at the initial and subsequent assessments for 
these 334 animals from 198 Group B herds are presented 
in Table 6. There was poor correlation between the initial 
and subsequent iELISA results (kappa = 0.39; 0.31, 
0.47; McNemar’s chi square test P < 0.001). There was 
also poor correlation between the CFT and iELISA results 
at the subsequent assessment (kappa = -0.17; -0.25, 
-0.09; McNemar’s chi square test P < 0.001) (Table 7). At 
this test, there were 56 animals in Group B herds with a 
positive CFT reading, including 40 (71.4%) that were also 
iELISA-positive.
At the subsequent assessment, the BST was conducted 
on 222 animals, including 12 (in 11 herds) that were 
positive (skin increase of at least 2 mm) (Table 8, Figure 5). 
CFT result (IU) No. of animals
0 3
13.9 4
16.7 15
19.4 4
28 8
33 1
39 8
44 1
56 5
67 7
78 3
111 4
133 3
156 2
178 4
222 6
266 1
311 3
356 34
Total 116
Table 1: The initial CFT results (international CFT units, IU) from 116 animals 
that were CFT- and/or iELISA-positive at the initial assessment in 10 Group A 
herds. A CFT result for one animal was not available
Table 2: The initial complement CFT (complement fixation test) and iELISA 
(indirect enzyme-linked immunosorbent assay) results from 116 animals that 
were CFT- and/or iELISA-positive at the initial assessment in 10 Group A herds. 
A CFT result for one additional animal was not available
CFT resulta iELISA result
Positive Negative Total
Positive 82 12 94
Negative 14 8 22
Total 96 20 116
a A CFT result of 19.4 international CFT units or greater was considered 
positive, and negative otherwise.
Table 3: The CFT (complement fixation test) and iELISA (indirect enzyme-linked 
immunosorbent assay) results from 441 animals that were CFT- and/or iELISA-
positive at the initial assessment in 246 Group B herds. CFT results for a further 
10 such animals were not available
CFT resulta iELISA result
Positive Negative Total
Positive 127 98 225
Negative 204 12 216
Total 331 110 441
a A CFT result of 19.4 international CFT units or greater was considered 
positive, and negative otherwise.
Past disease status
of index herd
Past disease status
of contuguous herd(s) Other indicators
Risk factors
Culture
10 animals
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CFT
iELISA
451 animals
247 herds
344 animals
201 herds
344 animals
198 herds
278 (83.2%) animals
Negative
(less than 19.4 IU)
56 (16.8%) animals
Positive
(less than 19.4 IU)
189 (56.6%) animals
Negative
145 (43.4%) animals
Positive
112 (33.5%) animals
Not tested
241 (72.2%) animals
Not tested 1 (1.1%) animals
Contaminated
1 (1.1%) animals
Positive
93 (27.8%) animals
Tested
Confirmed
1 (0.5%) herd
Clear
173 (87.3%) herds
No data
4 (2.0%) herds
No data
5 (2.5%) herds
Clear
172 (86.9%) herds
Restricted
not confirmed
20 (10.1%) herds
Restricted
not confirmed
9 (4.5%) herds
Confirmed
12 (6.1%) herds
Area problem or other
16 (8.1%) herds
None identified
173 (87.4%) herds
No data
9 (4.5%) herds
198 herds
91 (97.8%) animals
Negative
210 (94.6%) animals
Negative
(>2 mm increase)
12 (5.4%) animals
Positive
(2 mm increase
or greater)
107 animals
65 herds
Not re-bled
222 (66.5%) animals
Tested
Figure 5: Risk factors and diagnostic test results at the subsequent assessment 
for 334 study animals in 198 Group B herds.  A range of diagnostic tests are 
mentioned, including the complement fixation test (CFT), the indirect enzyme-
linked immunosorbent assay (iELISA) and the brucellin skin test (BST).
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There was a poor correlation between the CFT and the BST 
results (kappa = 0.03; -0.09, 0.14; McNemar’s chi square 
test P < 0.001; Table 9), and between the iELISA and BST 
results (kappa = 0.03; -0.05, 0.10; McNemar’s chi square 
test P < 0.001; Table 10). Bacterial culture was conducted 
on 93 animals from Group B herds, including one animal 
that tested positive (Figure 5).
Epidemiological information about 198 Group B herds 
is presented in Figure 5. On 21 farms, brucellosis had 
previously been reported on either the index and/or 
contiguous herd(s). 
A decision was taken by headquarters staff, in consulation 
with local staff, to depopulate 14 of the Group B herds, 
based on epidemiological and laboratory evidence, and 
after a qualitative risk assessment had been completed 
examining the potential risk of infection, and of spread, if 
infection were present. In four of these herds, there was 
an increase in CFT titre in at least one animal between the 
initial and subsequent assessment.
In the two years since study end, only one of the 246 
Group B herds disclosed any CFT reactors. Six animals 
were removed as reactors, and cultures of lymphatic 
tissues for B. abortus were negative. The herd was not 
depopulated and no further reactors were detected.
Group C herds
In the Group C herds, 398 animals from 382 herds were 
iELISA-positive at the initial serological assessment. Follow-
up data, including herd-level risk factor information and 
serological results were collected on 252 of these animals 
in 244 herds (Figure 6). At the subsequent assessment, there 
were two (0.8%) animals with a positive CFT reading and 
94 (37.3%) iELISA-positive animals (Figure 6). Epidemiological 
information about 198 Group C herds is presented in Figure 6. 
On five and 25 farms, respectively, brucellosis had previously 
been reported on the index and contiguous herd(s). Three 
Group C herds were depopulated. In the two years since 
study end, one Group C herd disclosed one positive CFT 
reactor. This herd was not depopulated (although this animal 
was removed), and no further reactors were detected.
DISCuSSION
In this study, we have sought to evaluate the infection 
status of Irish herds and animals with inconclusive 
serological evidence of bovine brucellosis. This assessment 
was essentially observational, relying on field and laboratory 
data collected as part of (and, in some cases, additional 
to) the nationally-directed disease eradication programme. 
Rapid herd depopulation has been an important component 
of the national programme for some years in situations 
where infection is likely. This approach was continued 
throughout the current study period, with CFT-positive 
animals being rapidly removed following detection. In 
addition, a decision to conduct full herd depopulations was 
undertaken centrally in several Group B and C herds, in 
consultation with local staff. These decisions were based on 
serological and other laboratory results and epidemiological 
information, and after a qualitative risk assessment had 
been completed examining the potential risk of infection, 
and of spread if infection were present. In the latter stages 
of the national programme (from 2003 onwards), it was 
considered prudent to rapidly depopulate some herds with 
less robust evidence of infection but where management 
practices (such as outdoor calvings) were considered 
to pose an unacceptable risk of infection spread. 
Consequently, during this study it was often not possible to 
conduct exhaustive laboratory tests to directly determine 
the infection status of these herds and animals. Rather, we 
have measured this indirectly, by considering the disease 
status of the index, contiguous and associated herds, for 
at least two years from the time of the initial test. In this 
way, we are evaluating the infection status of these study 
herds for at least two post-calving tests after disclosure of 
serological evidence of infection.
Although microbiological confirmation is available for 
only three of the ten Group A herds, it is more likely than 
not that each of these herds was infected, based on 
compelling serological and/or epidemiological evidence of 
infection. In the initial assessment of these herds, there 
were an average of 9.4 CFT-positive animals/herd. These 
Table 4: The summarised CFT (complement fixation test) results at the initial and 
subsequent assessment for 334 animals in 198 Group B herds. Each of these 
animals was CFT- and/or iELISA-positive at the initial assessment
Initial CFT resulta Subsequent CFT resulta
Positive Negative Total
Positive 51 122 173
Negative 5 156 161
Total 56 278 334
a A CFT result of 19.4 international CFT units or greater was considered 
positive, and negative otherwise.
Confirmed
1 (0.4%) herd
Clear
180 (73.8%) herds
No data
59 (24.2%) herds
No data
63 (25.8%) herds
Clear
156 (63.9%) herds
Restricted
not confirmed
4 (1.6%) herds
Restricted
not confirmed
14 (5.8%) herds
Confirmed
11 (4.5%) herds
Area problem or other
15 (6.2%) herds
None identified
167 (68.4%) herds
No data
62 (25.4%) herds
252 animals
rebled
Follow-up
diagnostic
testing
Risk Factors
244 herds
Culture
BST
CFT
iELISA
252 (100%) animals
rebled
1 (0.4%) animals
Haemolysed
249 (98.8%) animals
Negative
(less than 19.4 IU)
2 (0.8%) animals
Positive
(less than 19.4 IU)
245 (97.2%) animals
Not tested
245 (97.2%) animals
Not tested
7 (2.8%) animals
Tested
7 (2.8%) animals
Tested
252 (100%) animals
rebled
158 (62.7%) animals
Negative
7 (100%) animals
Negative
0 Animals
Positive
94 (37.3%) animals
Positive
4 (57.1%) animals
Negative
(<2mm increase)
3 (42.9%) animals
Positive
(<2mm increase
or greater)
Past disease status
of index herd
Past disease status
of contuguous herd(s) Other indicators
398 animals
382 herds
146 animals
Not rebled
Figure 6: Risk factors and diagnostic test results for 252 animals in 244 
Group C herds. A range of diagnostic tests are mentioned, including the 
complement fixation test (CFT), the indirect enzyme-linked immunosorbent 
assay (iELISA) and the brucellin skin test (BST).
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herds were rapidly depopulated following initial diagnosis, 
in line with national policy. A rigorous programme of post-
infection decontamination was then conducted in each of 
these herds, including the addition of lime into the slurry 
tank. In contrast, it is more likely than not that most of 
the Group B and C herds were not infected. Certainly, 
there was no evidence of within-herd transmission from 
any animals with CFT- and/or iELISA-positive results. To 
illustrate, based on ongoing serological monitoring over 
the intervening two years, there has been no evidence of 
Table 5: The detailed CFT (complement fixation test) results at the initial and subsequent assessment for 334 animals in 198 Group B herds. Each of these animals was 
CFT- and/or iELISA-positive at the initial assessment
Initial CFT 
result 
(international 
units)
Subsequent CFT result (international units)
0 13.9 16.7 19.4 22.2 28 33 39 44 56 67 111 133 178 311 356 Total
0 84 4 2 1 91
13.9 36 8 2 46
16.7 16 5 1 1 1 24
19.4 20 7 3 1 1 32
22.2 4 1 2 7
28 7 4 3 1 15
33 11 3 1 2 1 1 19
39 6 2 4 1 1 1 1 1 17
44 1 1 1 2 1 6
56 6 6 2 2 1 2 1 1 1 22
67 5 3 2 1 1 1 1 1 1 16
78 2 3 2 1 8
89 2 1 1 1 5
111 3 2 1 1 2 9
133 2 1 2 2 7
156 1 1
178 1 1 2
222 1 1
266 1 1
311 1 1
356 1 3 4
Total 203 51 24 8 1 7 10 8 4 1 3 4 1 1 1 7 334
Table 6: The iELISA (indirect enzyme-linked immunosorbent assay) results at the 
initial and subsequent assessment for 334 animals in 198 Group B herds. Each of 
these animals was CFT- and/or iELISA-positive at the initial assessment
Initial iELISA 
result
Subsequent iELISA result
Positive Negative Total
Positive 141 104 245
Negative 4 85 89
Total 145 189 334
Table 7: The CFT (complement fixation test) and iELISA (indirect enzyme-linked 
immunosorbent assay) results from 334 animals in 198 Group B herds at the 
subsequent assessment. Each of these animals was CFT- and/or iELISA-positive at 
the initial assessment
CFT resulta iELISA result
Positive Negative Total
Positive 16 40 56
Negative 173 105 278
Total 189 145 334
a A CFT result of 19.4 international CFT units or greater was considered 
positive, and negative otherwise.
Table 8: The detailed CFT (complement fixation test) and BST (brucellin skin test) 
results from 222 animals in 146 Group B herds at the subsequent assessment. 
Each of these animals was CFT- and/or iELISA positive at the initial assessment
CFT 
resulta
BST resultb
0 0.5 1 2 3 4 5  >5 Total
Positive 34 6 1 0 0 2 0 43
Negative 162 1 7 5 2 0 1 1 179
Total 196 1 13 6 2 0 3 1 222
a A CFT result of 19.4 international CFT units or greater was considered 
positive, and negative otherwise; and,
b A measurement of 2 mm or greater was considered positive, and negative 
otherwise.
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infection in 231 (93.9% of 246) Group B herds and 378 
(99.0% of 382) Group C herds. We accept that infection 
may have been present in the other Group B and C herds, 
noting that 14 Group B and three Group C herds were 
rapidly depopulated at the time of initial investigation. 
CFT-positive animals were disclosed in one Group B herd 
and one Group C herd, in this two year period, however, 
drawing on all available evidence, these two herds were not 
depopulated, and have disclosed no further reactors.
In Ireland, the CFT is currently used as the primary 
confirmatory diagnostic test for brucellosis, with the iELISA 
and the BST providing supplementary information. The CFT 
and iELISA are each considered prescribed tests for trade 
internationally (OIE 2004) and within the European Union 
(Anon. 1964), whereas the BST is considered either an 
‘other’ (OIE 2004) or complementary (Anon. 1964) test 
(EFSA 2006). Other tests, such as the competitive enzyme-
linked immunosorbent assay (cELISA), the fluorescence 
polarisation assay (FPA) and the rose Bengal plate test 
(RBT) were not considered in this paper, as they are not 
part of the decision making process in the Irish brucellosis 
eradication programme. The serological diagnosis of 
brucellosis has been an area of intensive study over 
many years (for example: Neilson 2002; Special Edition of 
Veterinary Microbiology vol. 90, no. 3-4, 2002; EFSA 2006).
This study presents useful insights into the relative 
performance of those tests that are currently in use in 
the Irish programme. Any interpretation of the absolute 
performance (and particularly the specificity) of these tests 
must be undertaken with care, noting that we are not able 
to definitively distinguish true from false positive results. 
As noted previously, most (but not all) of the test-positive 
animals in Group B and C herds were believed to be false-
positive results.
In this study, a negative or falling CFT titre on the second 
or subsequent test was highly suggestive that the result 
was a false-positive. Serological responses generally 
followed this pattern in both Group B and Group C herds. 
In the Group B herds, 173 animals were CFT-positive at the 
initial, but only 56 (32.4%) at the subsequent assessment 
(Table 4, Figure 5). In general, the CFT titre tended to persist 
on the second or subsequent test if a high titre was 
recorded initially (Figure 5). In the Group C herds, only two 
(0.8%) of the 252 study animals were CFT-positive on the 
subsequent test (Figure 6). We accept that reliance should 
not be placed on serology alone, noting that non-pregnant 
heifers may give a weak and transient response to a 
challenge with Brucella organisms (Cunningham 1968; 
Wilkinson et al. 1988). Pregnant heifers may present a 
similar serological picture (Cunningham 1968). False-
positive results, which often present as a positive, but 
falling titre in one or a small proportion of the herd, have 
traditionally been attributed to infection with cross-reacting 
organisms (Corbel et al. 1984). The specificity of the CFT 
test may be compromised when animal populations are 
infected with Yersinia enterocolitica 0:9 (Godfroid and 
Käsbohrer 2002; Godfroid et al. 2002). Godfroid et al. 
(2002) have found that the different brucellosis serological 
tests could not differentiate brucellosis from infection 
with Y. enterocolitica 0:9, whereas the BST could. Recent 
findings (as yet unpublished) confirm the presence of 
infection with Y. enterocolitica 0:9 in some Irish herds, 
which may be leading to false-positive CFT reactions. 
Further work is underway to quantify this problem.
In this study, there was variable, but often poor, 
correlation between each of the three diagnostic tests 
under investigation. In the Group B herds, there was 
poor correlation between CFT and iELISA results at 
both the initial (kappa = -0.38, Table 3) and subsequent 
assessment (kappa = -0.25, Table 7). In contrast, there 
was moderate agreement between these tests in animals 
from Group A herds (kappa = 0.24, Table 2). Also, there 
was poor correlation between the BST, and both the CFT 
(kappa = 0.03, Table 8 and Table 9) and iELISA (kappa = 0.03, 
Table 10) results from Group B herds. These results confirm 
our experience with the iELISA, noting that iELISA-positive 
but CFT-negative results are not uncommon. These results 
are consistent with those from a recent detailed meta-
analysis, where the iELISA had a generally higher sensitivity 
but lower specificity that the CFT (EFSA, 2006). 
Within Annex C of EU Directive 64/432/EEC (Anon. 1964), 
the BST is classified a ‘complementary test’, to assist in 
distinguishing false and true positive reactors following 
testing with prescribed ‘standard tests’ (iELISA, CFT, 
MSAT, Rose Bengal test). It has been reported that the 
BST, depending on the source of the brucellin, is highly 
specific (greater than 99%), and with moderate to high 
sensitivity (64-93%) (Pouillot et al. 1997; Saegerman et al. 
1999; Bercovich and Muskens 1999) that decreases with 
increasing time following infection (Saegerman et al. 1999). 
In the meta-analysis above-mentioned, however, there were 
Table 9: The summarised CFT (complement fixation test) and BST (brucellin 
skin test) results from 222 animals in 146 Group B herds at the subsequent 
assessment. Each of these animals was CFT- and/or iELISA-positive at the initial 
assessment
CFT resulta BST resultb
Positive Negative Total
Positive 3 40 43
Negative 9 170 179
Total 12 210 222
a A CFT result of 19.4 international CFT units or greater was considered 
positive, and negative otherwise; and, 
b A measurement of 2 mm or greater was considered positive, and negative 
otherwise.
Table 10: The iELISA (indirect enzyme-linked immunosorbent assay) and BST 
(brucellin skin test) results from 222 animals in 146 Group B herds at the 
subsequent assessment. Each of these animals was CFT- and/or iELISA-positive 
at the initial assessment
iELISA result BST resulta
Positive Negative Total
Positive 6 83 89
Negative 6 127 133
Total 12 210 222
a A measurement of 2 mm or greater was considered positive, and negative 
otherwise.
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insufficient data to estimate sensitivity and specificity. In 
the current study, it has not been possible to estimate the 
absolute performance of the BST. Brucellergene OCB is 
currently not available from Synbiotics Europe, however, we 
understand that attempts are being made to re-establish 
commercial production.
As part of this study, data on a range of epidemiological risk 
factors was collected from each of the Group B and C herds, 
including the past disease status of the index and contiguous 
herds, and other potential indicators of infection including 
the presence (or otherwise) of infection in the locality. The 
distribution of these risk factors between Group B and C 
herds is not dissimilar, and may reflect – at least in part 
– the historically widespread nature of infection in Ireland. 
For example, in 6.1% and 4.6% of Group B and C herds, 
respectively, there is a past history of confirmed disease 
in one or more contiguous herds. Nonetheless, among the 
Group A herds, and those Group B herds where disease was 
subsequently suspected, a combined understanding of all 
relevant information (including epidemiological risk factors) 
contributed to effective decision-making.
CONCluSION
Current serological tests for brucellosis have imperfect 
specificity; therefore, seropositive results during brucellosis 
testing will continue after Brucella abortus has been 
successfully eradicated (Godfroid et al. 2002). During the 
latter stages of the Irish eradication programme, there has 
been a need for science-based information, both serological 
and epidemiological, relevant to a managed, risk-based 
move away from full-herd depopulation. Knowledge of the 
CFT reading at the initial and a subsequent blood test 
proved useful in distinguishing false positive and true 
positive brucellosis results. In addition, the iELISA was 
more sensitive, but less specific than the CFT test. As 
a result of these findings, the national policy has been 
modified to include re-sampling of all animals with CFT 
readings of 20 IU or greater. The BST may help to clarify 
true- and false-positive results, noting the potential for 
serological cross-reaction with Yersinia enterocolitica 
serotype 0:9. This project has also led to a reduction in the 
number of herds restricted, as well as restriction duration. 
It has also contributed to a reduction in the number 
of herds listed for contiguous tests, and therefore the 
potential for contiguity testing of false positive results.
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The Usual Suspects
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The Evidence: In Ireland approximately one in five cattle will develop endometritis this year
1. That’s almost
400,000 cattle with serious fertility problems. The majority of these will not be diagnosed because they won’t present any
visible signs.
The Suspects: But, there is an identifiable “At Risk” group that has a very high chance of developing
endometritis. Treatment of these cattle as a group has been shown to improve herd fertility.
2
The Proof: A treatment for endometritis must achieve more than the elimination of a discharge;
It should have a positive effect on fertility in the animals as well. 
Metricure is the only licensed antibiotic treatment for subacute and chronic endometritis that has been proven to
improve subsequent reproductive performance.
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